Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Premature birth alters brain connections

  • Researchers hope to improve dental health by changing caregiver's behavior

  • Study points to possible treatment for lethal pediatric brain cancer

  • Youth just as likely to try e-cigarettes as smoking

  • Combining computer vision, brain computer interface for faster mine detection

  • Scientists reconcile three unrelated theories of schizophrenia

  • Cellular bubbles used to deliver Parkinson's meds directly to brain

  • Personal cues can have a strong effect on craving in individuals with addiction

  • How chickenpox virus can cause a stroke in an HIV patient

  • Impact of family, neighborhood on mental health revealed in comprehensive study

  •